← Eichor
Study identifier: NCT05435794 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients

Condition: OSA  ·  Sponsor: ResMed

PhaseN/A
Planned participants400
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The REMAP study aims to follow a cohort of 400 patients in around ten sleep centers in France and to collect clinical routine data. The objectives of this study are to investigate the effects of one-year management of OSA by CPAP or MAD on sleep architecture defined by objective macro and micro sleep architecture parameters using a sleep test device. sleep connected at home, to assess the quality of sleep and the quality of life reported by patients. The study will also allow us to define predictive factors for improving sleep quality during OSA treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Elodie Aversenq  ·  +33426100200  ·  elodie.aversenq@resmed.fr

Florent Lavergne  ·  +33426100200  ·  florent.lavergne@resmed.fr

Always discuss trial participation with your own doctor first.

Locations (9)

CHU AngersAngers, FranceRecruiting
Centre Hospitalier Universitaire Grenoble AlpesGrenoble, FranceRecruiting
CHU Lyon - Hôpital de la Croix-RousseLyon, FranceRecruiting
Hopital Europeen MarseilleMarseille, FranceRecruiting
APHP - Pitié-Salpêtrière University HospitalParis, FranceRecruiting
AP-HP BichatParis, FranceNot Yet Recruiting
CHU ReimsReims, FranceRecruiting
Polyclinique St LaurentRennes, FranceRecruiting
Centre du SommeilSaint-Martin-d'Hères, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05435794